Parenteral methotrexate or gold for rheumatoid arthritis: a follow up.
The forty participants in a double blind controlled trial of parenteral methotrexate or gold for RA were followed up two years later. Fifty percent had remained on the original medication, 13/20 on MTX and 7/20 on gold. Only 5 and 3 of them respectively had no active joint swelling. No major differences between the two groups were seen.
Suarez-Almazor
M E
ME
Department of Medicine, University of Alberta, Canada.
Russell
A S
AS
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006052:Gold Sodium Thiomalate / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010352:Patient Dropouts; D013997:Time Factors
D006052:Gold Sodium Thiomalate; D008727:Methotrexate